Mesenchymal Stem Cell Exosomes(Ripson Institute Of Stem Cell Regenerative Medicine)
间充质干细胞外泌体(瑞普逊干细胞再生医学研究院)
Report date: 2025/02/28 10:17:20
Base Information
Drug NameMesenchymal Stem Cell Exosomes(Ripson Institute Of Stem Cell Regenerative Medicine)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Ripson Institute Of Stem Cell Regenerative Medicine
China Registration ClassN/A
Develop Information
Active CompaniesShenzhen Ripson Institute Of Stem Cell Regenerative Medicine
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A